ASIC3 Polyclonal Antibody

ASIC3 encodes a member of the degenerin/epithelial sodium channel (DEG/ENaC) superfamily. The members of this family are amiloride-sensitive sodium channels that contain intracellular N and C termini, two hydrophobic transmembrane regions, and a large extracellular loop, which has many cysteine residues with conserved spacing. The member encoded by this gene is an acid sensor and may play an important role in the detection of lasting pH changes. In addition, a heteromeric association between this member and acid-sensing (proton-gated) ion channel 2 has been observed as proton-gated channels sensitive to gadolinium. Alternatively spliced transcript variants have been described.

The ASIC3 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Acid-Sensing Ion Channel 3 (ASIC3) protein expression. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards ASIC3.

The ASIC3 Polyclonal Antibody is suitable for various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated in multiple experimental models, demonstrating its exceptional performance and accuracy.

With its exceptional sensitivity, this antibody allows for the precise detection of ASIC3 protein expression in various tissues and cell types. Its robust performance ensures reliable and reproducible results, making it an ideal choice for both research and diagnostic purposes.

The ASIC3 Polyclonal Antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming preparations. It is provided in a sufficient quantity to perform multiple experiments, ensuring cost-effectiveness and convenience.

In summary, the ASIC3 Polyclonal Antibody is a highly reliable and specific tool for the detection and analysis of ASIC3 protein expression. Its exceptional sensitivity, robust performance, and convenient format make it an excellent choice for researchers and clinicians alike.